Literature DB >> 20180904

Thrombin upregulates the angiopoietin-Tie2 Axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P-selectin from Weibel-Palade bodies.

J-S Bae1, A R Rezaie.   

Abstract

SUMMARY
BACKGROUND: Activated protein C (APC) in complex with endothelial protein C receptor (EPCR) can reverse the barrier-disruptive and cytotoxic effects of proinflammatory cytokines by cleaving protease-activated receptor 1 (PAR-1). Recently, it was reported that the PAR-1-dependent vascular barrier-protective effect of APC is mediated through transactivation of the angiopoietin (Ang)-Tie2 signaling pathway. The antagonist of this pathway, Ang2, is stored in Weibel-Palade bodies within endothelial cells.
OBJECTIVES: To determine whether the occupancy of EPCR by its ligand can switch the PAR-1-dependent signaling specificity of thrombin through the Ang-Tie2 axis.
METHODS: We activated endothelial cells with thrombin before and after treating them with the catalytically inactive Ser195-->Ala substitution mutant of protein C. The expression levels of Ang1, Ang2 and Tie2 in response to thrombin were measured by both an enzyme-linked immunosorbent assay and a cell permeability assay in the absence and presence of small interfering RNA and a blocking antibody to Tie2.
RESULTS: Thrombin upregulated the expression of both Ang1 and Tie2 but downregulated the expression of Ang2 when EPCR was occupied by its ligand. The Ang1-Tie2-dependent protective effect of thrombin was initiated through protein C inhibiting the rapid mobilization of Ang2 from Weibel-Palade bodies. Interestingly, the protein C mutant also inhibited the thrombin mobilization of P-selectin.
CONCLUSIONS: These results suggest a physiologic role for the low concentration of thrombin in maintaining the integrity of the EPCR-containing vasculature through the PAR-1-dependent inhibition of Ang2 and P-selectin release from Weibel-Palade bodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180904      PMCID: PMC2891946          DOI: 10.1111/j.1538-7836.2010.03812.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  19 in total

Review 1.  Selectins: novel receptors that mediate leukocyte adhesion during inflammation.

Authors:  R P McEver
Journal:  Thromb Haemost       Date:  1991-03-04       Impact factor: 5.249

2.  Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.

Authors:  James H Finigan; Steven M Dudek; Patrick A Singleton; Eddie T Chiang; Jeffrey R Jacobson; Sara M Camp; Shiu Q Ye; Joe G N Garcia
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

3.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice.

Authors:  T N Mayadas; R C Johnson; H Rayburn; R O Hynes; D D Wagner
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

4.  PAR1 cleavage and signaling in response to activated protein C and thrombin.

Authors:  Matthew J Ludeman; Hiroshi Kataoka; Yoga Srinivasan; Naomi L Esmon; Charles T Esmon; Shaun R Coughlin
Journal:  J Biol Chem       Date:  2005-01-21       Impact factor: 5.157

5.  Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions.

Authors:  J R Gamble; J Drew; L Trezise; A Underwood; M Parsons; L Kasminkas; J Rudge; G Yancopoulos; M A Vadas
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

6.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

7.  Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1.

Authors:  Xiaochun Li; Christopher N Hahn; Michelle Parsons; Jenny Drew; Mathew A Vadas; Jennifer R Gamble
Journal:  Blood       Date:  2004-06-01       Impact factor: 22.113

8.  Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Authors:  Matthias Riewald; Ramona J Petrovan; Aaron Donner; Barbara M Mueller; Wolfram Ruf
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

9.  Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function.

Authors:  Nikita Minhas; Meilang Xue; Kenji Fukudome; Christopher J Jackson
Journal:  FASEB J       Date:  2009-10-26       Impact factor: 5.191

10.  Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo.

Authors:  Mitsuhiro Uchiba; Kenji Okajima; Yuichi Oike; Yasuhiro Ito; Kenji Fukudome; Hirotaka Isobe; Toshio Suda
Journal:  Circ Res       Date:  2004-05-27       Impact factor: 17.367

View more
  23 in total

1.  Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.

Authors:  Shunsuke Kanou; Tomoharu Miyashita; Yasuhiko Yamamoto; Satoshi Takada; Makoto Nakura; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Shinichi Nakanuma; Isamu Makino; Hidehiro Tajima; Hiroyuki Takamura; Sachio Fushida; Tetsuo Ohta
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding.

Authors:  Corey E Tabit; Phetcharat Chen; Gene H Kim; Savitri E Fedson; Gabriel Sayer; Mitchell J Coplan; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  Circulation       Date:  2016-06-28       Impact factor: 29.690

3.  Noncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.

Authors:  Fabian Stavenuiter; Laurent O Mosnier
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

Review 4.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 5.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 6.  Endothelial cell protein C receptor: a multiliganded and multifunctional receptor.

Authors:  L Vijaya Mohan Rao; Charles T Esmon; Usha R Pendurthi
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

7.  Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar.

Authors:  Omozuanvbo Aisiku; Christian G Peters; Karen De Ceunynck; Chandra C Ghosh; James R Dilks; Susanna F Fustolo-Gunnink; Mingdong Huang; Chris Dockendorff; Samir M Parikh; Robert Flaumenhaft
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

8.  Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function.

Authors:  Nikita Minhas; Meilang Xue; Christopher J Jackson
Journal:  Cell Mol Life Sci       Date:  2016-12-22       Impact factor: 9.261

Review 9.  Functional architecture of Weibel-Palade bodies.

Authors:  Karine M Valentijn; J Evan Sadler; Jack A Valentijn; Jan Voorberg; Jeroen Eikenboom
Journal:  Blood       Date:  2011-01-25       Impact factor: 22.113

Review 10.  The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling.

Authors:  Eimear M Gleeson; James S O'Donnell; Roger J S Preston
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.